The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services ...
The 2025-2027 approval helps French innovators access Intravacc's vaccine development, analytical development and cGMP manufacturing services French Ministry approval recognizes Intravacc as a private ...
Pfizer (PFE) stock is in focus as the company starts Phase 3 infant trials for the 25-valent pneumococcal vaccine after ...
Eli Lilly has agreed to acquire three privately-held developers of vaccines for infectious diseases for a combined up-to-$3.83 billion cash, in deals intended to expand the acquisitive pharma giant’s ...
Marine organisms have evolved a remarkable arsenal of host-defense peptides under conditions of extreme variability and ...
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated ...
OPUS-2 and OPUS-3 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults Topline Safety, Tolerability and Immunogenicity Data from OPUS-1 Expected ...
The standard response to antimicrobial resistance (AMR) focuses on restricting antibiotic use, including better prescribing practices, tighter pharmacy regulations, and reduced over-the-counter sales.
OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in gene-edited, listeria-based ...
Sales of products produced under PLI scheme for pharma exceeded target: DoP: Gireesh Babu, New Delhi Friday, May 15, 2026, 08:00 Hrs [IST] Sales of pharmaceutical products produce ...
OS Therapies, Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in gene-edited, listeria-based cancer immunotherapies, announced Dr. Craig Eagle’s appointment as Chief ...
OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in gene-edited, listeria-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results